Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05829889 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial
NCT05829889 · ClinicalTrials.gov record · last posted 2026-06-24

Fractional Flow Reserve Versus Angiography for Treatment-Decision and Evaluation of Significant Left MAIN Coronary Artery Disease

Study acronym: FATE-MAIN
StatusRecruiting
PhaseNot applicable
Started2024-04-25
View on ClinicalTrials.gov ↗
from the ClinicalTrials.gov record
The primary purpose of the study was to determine whether the 2-year probability of major adverse cardiac events (primary composite outcome) differed significantly between patients who underwent angiography-guided Percutaneous Coronary Intervention(PCI) and those who underwent Fractional Flow Reserve(FFR)-guided PCI in patients with Left Main Coronary Artery disease(LMCA).

Amendment record 10 amendments on the ClinicalTrials.gov record

This ClinicalTrials.gov record has been amended 10 times since 2023-04-13; most recent amendment 2026-06-23. DataLookout shows field-level changes from the day a trial enters its daily monitoring; earlier amendments are counted here from the ClinicalTrials.gov version history. See every version on ClinicalTrials.gov ↗

2024-04-24
Status change Not Yet Recruiting→Recruitingv5
Trial Details
NCT Number NCT05829889
Lead Sponsor Seung-Jung Park
Collaborators: CardioVascular Research Foundation, Korea
Conditions Coronary Artery Disease Left Main, Coronary Artery Disease
Enrollment 960 participants
Start Date 2024-04-25
Primary Completion 2027-06 (estimated)
Study Completion 2027-12 (estimated)
Updated on ClinicalTrials.gov 2026-06-24